| 2019-01-01 |
Choi IS et al., Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge. J Cardiovasc Pharmacol Ther. 2019 (in press) |
| 2018-01-01 |
Park SJ et al., Urinary and Blood microRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: A Meta-analysis. Cellular Physiology and Biochemistry 2018;46(4):1331-1340. |
| 2018-01-01 |
Cho JL et al., Statin has more protective effects in AMI patients with higher plasma BNP or NT-proBNP level, but not with lower left ventricular ejection fraction. Journal of Cardiology 71 (4) (2018) 375–381 |
| 2017-09-21 |
Lee ES et al., Sodium butyrate has context-dependent actions on dipeptidyl peptidase-4 and other metabolic parameters. The Korean Journal of Physiology & Pharmacology 2017 Sep; 21(5): 519-529 |
| 2017-03-21 |
Lamichhane S et al., ROS production and ERK activity are involved in the effects of D-beta-hydroxybutyrate and metformin in a glucose deficient condition. Int J Mol Sci. 2017 Mar 21;18(3). pii: E674 |
| 2017-01-01 |
Ko SC et al., Anti-hypertensive effect of an enzymatic hydrolysate from Styela clava flesh tissue in type 2 diabetic patients with hypertension. Nutrition Research and Practice 2017;11(5):396-401 |
